$GNSC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENAISSANCE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENAISSANCE PHARMACEUTICALS INC. Get notifications about new insider transactions in GENAISSANCE PHARMACEUTICALS INC for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 2.20 | 135,000 | 297,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 3.74 | 60,000 | 224,400 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 2.56 | 140,000 | 358,400 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 0.85 | 75,000 | 63,750 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 5.00 | 50,000 | 250,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 2.50 | 50,000 | 125,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 3.80 | 100,000 | 380,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 12.00 | 400,000 | 4,800,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Sell | D | 0.00 | 95,000 | 0 | 0 | 95 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Sell | D | 0.00 | 584,094 | 0 | 0 | 584.1 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | DREWS JURGEN | Director | Option Exercise | D | 3.10 | 10,000 | 31,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | DREWS JURGEN | Director | Option Exercise | D | 2.10 | 5,000 | 10,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | DREWS JURGEN | Director | Option Exercise | D | 0.50 | 5,000 | 2,505 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | DREWS JURGEN | Director | Option Exercise | D | 3.75 | 5,000 | 18,750 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | DREWS JURGEN | Director | Option Exercise | D | 19.94 | 25,000 | 498,438 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | DREWS JURGEN | Director | Sell | D | 0.00 | 26,393 | 0 | 0 | 26.4 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KAPLAN BEN D | Sr. VP, CFO & Secre ... | Option Exercise | D | 2.20 | 60,000 | 132,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KAPLAN BEN D | Sr. VP, CFO & Secre ... | Option Exercise | D | 3.74 | 30,000 | 112,200 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KAPLAN BEN D | Sr. VP, CFO & Secre ... | Option Exercise | D | 2.56 | 65,000 | 166,400 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KAPLAN BEN D | Sr. VP, CFO & Secre ... | Option Exercise | D | 1.25 | 200,000 | 250,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KAPLAN BEN D | Sr. VP, CFO & Secre ... | Sell | D | 0.00 | 2,000 | 0 | 0 | 2 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KAPLAN BEN D | Sr. VP, CFO & Secre ... | Sell | D | 0.00 | 29,000 | 0 | 0 | 29 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | DAWES KAREN A | Director | Option Exercise | D | 3.10 | 10,000 | 31,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | DAWES KAREN A | Director | Option Exercise | D | 1.90 | 10,000 | 19,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | DAWES KAREN A | Director | Sell | D | 0.00 | 17,989 | 0 | 0 | 18 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 2.20 | 85,000 | 187,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 3.74 | 30,000 | 112,200 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 2.56 | 70,000 | 179,200 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 0.85 | 50,000 | 42,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 2.50 | 25,000 | 62,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 4.50 | 25,000 | 112,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 8.25 | 35,000 | 288,750 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 12.00 | 20,000 | 240,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 10.00 | 50,000 | 500,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 3.00 | 42,000 | 126,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | D | 3.00 | 3,000 | 9,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Sell | D | 0.00 | 54,950 | 0 | 0 | 55 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 2.20 | 60,000 | 132,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 3.74 | 30,000 | 112,200 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 2.56 | 70,000 | 179,200 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 0.85 | 50,000 | 42,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 2.50 | 35,000 | 87,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 4.50 | 25,000 | 112,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 8.25 | 35,000 | 288,750 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 12.00 | 20,000 | 240,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 10.00 | 25,000 | 250,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Option Exercise | D | 3.00 | 93,750 | 281,250 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Executive VP & CTO | Sell | D | 0.00 | 56,454 | 0 | 0 | 56.5 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Option Exercise | D | 3.10 | 10,000 | 31,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Option Exercise | D | 2.10 | 5,000 | 10,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Option Exercise | D | 0.50 | 5,000 | 2,505 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Option Exercise | D | 3.75 | 5,000 | 18,750 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Option Exercise | D | 19.94 | 10,000 | 199,375 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Option Exercise | D | 4.00 | 5,000 | 20,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Option Exercise | D | 3.00 | 20,000 | 60,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Sell | D | 0.00 | 40,389 | 0 | 0 | 40.4 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KLEIN JOSEPH III | Director | Option Exercise | D | 2.00 | 10,000 | 20,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KLEIN JOSEPH III | Director | Option Exercise | D | 3.10 | 10,000 | 31,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KLEIN JOSEPH III | Director | Option Exercise | D | 2.10 | 5,000 | 10,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KLEIN JOSEPH III | Director | Option Exercise | D | 1.67 | 10,000 | 16,700 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | KLEIN JOSEPH III | Director | Sell | D | 0.00 | 56,789 | 0 | 0 | 56.8 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Option Exercise | D | 3.10 | 10,000 | 31,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Option Exercise | D | 2.10 | 5,000 | 10,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Option Exercise | D | 0.50 | 5,000 | 2,505 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Option Exercise | D | 3.75 | 5,000 | 18,750 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Option Exercise | D | 19.94 | 10,000 | 199,375 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Sell | D | 0.00 | 232,970 | 0 | 0 | 233 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Sell | D | 0.00 | 131 | 0 | 0 | 131 to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Sell | D | 0.00 | 27,379 | 0 | 0 | 27.4 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Option Exercise | D | 1.69 | 236,686 | 399,999 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Option Exercise | D | 3.10 | 10,000 | 31,000 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Option Exercise | D | 2.10 | 5,000 | 10,500 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Option Exercise | D | 0.50 | 5,000 | 2,505 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Option Exercise | D | 3.75 | 5,000 | 18,750 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Option Exercise | D | 19.94 | 10,000 | 199,375 | 0 | |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Sell | D | 0.00 | 570,507 | 0 | 0 | 570.5 K to 0 (-100.00 %) |
Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Sell | D | 0.00 | 22,363 | 0 | 0 | 22.4 K to 0 (-100.00 %) |
Jul 21 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 7,589 | 0 | 40,389 | 32.8 K to 40.4 K (+23.14 %) |
Jul 21 2005 | GNSC | GENAISSANCE PHARMA ... | DREWS JURGEN | Director | Grant | A | 0.00 | 13,393 | 0 | 26,393 | 13 K to 26.4 K (+103.02 %) |
Jul 21 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Grant | A | 0.00 | 7,143 | 0 | 27,379 | 20.2 K to 27.4 K (+35.30 %) |
Jul 21 2005 | GNSC | GENAISSANCE PHARMA ... | KLEIN JOSEPH III | Director | Grant | A | 0.00 | 7,589 | 0 | 56,789 | 49.2 K to 56.8 K (+15.42 %) |
Jul 21 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Grant | A | 0.00 | 9,263 | 0 | 22,363 | 13.1 K to 22.4 K (+70.71 %) |
Jul 21 2005 | GNSC | GENAISSANCE PHARMA ... | DAWES KAREN A | Director | Grant | A | 0.00 | 7,589 | 0 | 17,989 | 10.4 K to 18 K (+72.97 %) |
Apr 26 2005 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Grant | A | 0.00 | 9,600 | 0 | 20,236 | 10.6 K to 20.2 K (+90.26 %) |
Apr 26 2005 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 12,800 | 0 | 32,800 | 20 K to 32.8 K (+64.00 %) |
Apr 26 2005 | GNSC | GENAISSANCE PHARMA ... | DREWS JURGEN | Director | Grant | A | 0.00 | 12,000 | 0 | 13,000 | 1,000 to 13 K (+1,200.00 %) |
Apr 26 2005 | GNSC | GENAISSANCE PHARMA ... | KLEIN JOSEPH III | Director | Grant | A | 0.00 | 9,200 | 0 | 49,200 | 40 K to 49.2 K (+23.00 %) |
Apr 26 2005 | GNSC | GENAISSANCE PHARMA ... | DAWES KAREN A | Director | Grant | A | 0.00 | 10,400 | 0 | 10,400 | 0 to 10.4 K |
Apr 26 2005 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Grant | A | 0.00 | 13,100 | 0 | 13,100 | 0 to 13.1 K |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | BALEZENTIS CARL W | Sr. V.P & President ... | Option Exercise | A | 2.20 | 60,000 | 132,000 | 60,000 | |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | BALEZENTIS CARL W | Sr. V.P & President ... | Grant | A | 0.00 | 20,000 | 20 | 20,000 | 0 to 20 K |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Exec. VP & CTO | Option Exercise | A | 2.20 | 60,000 | 132,000 | 60,000 | |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Exec. VP & CTO | Grant | A | 0.00 | 20,000 | 20 | 56,454 | 36.5 K to 56.5 K (+54.86 %) |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | Pres. and CEO | Option Exercise | A | 2.20 | 135,000 | 297,000 | 135,000 | |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | Pres. and CEO | Grant | A | 0.00 | 35,000 | 35 | 617,094 | 582.1 K to 617.1 K (+6.01 %) |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | KAPLAN BEN D | Sr. VP, CFO & Secre ... | Option Exercise | A | 2.20 | 60,000 | 132,000 | 60,000 | |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | KAPLAN BEN D | Sr. VP, CFO & Secre ... | Grant | A | 0.00 | 25,000 | 25 | 29,000 | 4 K to 29 K (+625.00 %) |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | Kalnik Matthew Walter | Sr. V.P., Business ... | Option Exercise | A | 2.20 | 75,000 | 165,000 | 75,000 | |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | Kalnik Matthew Walter | Sr. V.P., Business ... | Grant | A | 0.00 | 25,000 | 25 | 25,500 | 500 to 25.5 K (+5,000.00 %) |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | A | 2.20 | 85,000 | 187,000 | 85,000 | |
Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Grant | A | 0.00 | 25,000 | 25 | 54,950 | 30 K to 55 K (+83.47 %) |
Oct 04 2004 | GNSC | GENAISSANCE PHARMA ... | DAWES KAREN A | Director | Option Exercise | A | 3.10 | 10,000 | 31,000 | 10,000 | |
Oct 04 2004 | GNSC | GENAISSANCE PHARMA ... | KLEIN JOSEPH III | Director | Option Exercise | A | 3.10 | 10,000 | 31,000 | 10,000 | |
Oct 04 2004 | GNSC | GENAISSANCE PHARMA ... | PENNER HARRY JR | Director | Option Exercise | A | 3.10 | 10,000 | 31,000 | 10,000 | |
Oct 04 2004 | GNSC | GENAISSANCE PHARMA ... | RUDNICK SETH | Director | Option Exercise | A | 3.10 | 10,000 | 31,000 | 10,000 | |
Oct 04 2004 | GNSC | GENAISSANCE PHARMA ... | WRIGHT CHRISTOPHER | Director | Option Exercise | A | 3.10 | 10,000 | 31,000 | 10,000 | |
Oct 04 2004 | GNSC | GENAISSANCE PHARMA ... | DREWS JURGEN | Director | Option Exercise | A | 3.10 | 10,000 | 31,000 | 10,000 | |
Aug 11 2004 | GNSC | GENAISSANCE PHARMA ... | Kalnik Matthew Walter | Sr. V.P., Business ... | Option Exercise | A | 2.95 | 175,000 | 516,075 | 175,000 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | Pres. and CEO | Option Exercise | A | 3.74 | 60,000 | 224,400 | 60,000 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | Pres. and CEO | Gift | G | 0.00 | 2,500 | 0 | 582,094 | 584.6 K to 582.1 K (-0.43 %) |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | VOVIS GERALD | Exec. VP & CTO | Option Exercise | A | 3.74 | 30,000 | 112,200 | 30,000 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | JUDSON RICHARD | Senior VP & CSO | Option Exercise | A | 3.74 | 30,000 | 112,200 | 30,000 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | KAPLAN BEN D | Sr. VP, CFO & Secre ... | Option Exercise | A | 3.74 | 30,000 | 112,200 | 30,000 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | BALEZENTIS CARL W | SVP & President, La ... | Option Exercise | A | 0.88 | 58,186 | 51,204 | 58,186 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | BALEZENTIS CARL W | SVP & President, La ... | Option Exercise | A | 0.66 | 108,600 | 71,676 | 108,600 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | BALEZENTIS CARL W | SVP & President, La ... | Option Exercise | A | 0.66 | 63,350 | 41,811 | 63,350 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | BALEZENTIS CARL W | SVP & President, La ... | Option Exercise | A | 0.66 | 31,675 | 20,906 | 31,675 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | BALEZENTIS CARL W | SVP & President, La ... | Option Exercise | A | 0.66 | 31,675 | 20,906 | 31,675 | |
Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | BALEZENTIS CARL W | SVP & President, La ... | Option Exercise | A | 3.49 | 100,000 | 349,000 | 100,000 | |
Feb 26 2004 | GNSC | GENAISSANCE PHARMA ... | BLACK HILL INVESTMENT ADVISORS ... | 10% Owner | Sell | S | 3.96 | 2,000 | 7,920 | 795,500 | 797.5 K to 795.5 K (-0.25 %) |
Feb 26 2004 | GNSC | GENAISSANCE PHARMA ... | BLACK HILL INVESTMENT ADVISORS ... | 10% Owner | Sell | S | 4.07 | 20,000 | 81,400 | 797,500 | 817.5 K to 797.5 K (-2.45 %) |
Feb 26 2004 | GNSC | GENAISSANCE PHARMA ... | BLACK HILL INVESTMENT ADVISORS ... | 10% Owner | Sell | S | 3.93 | 2,200 | 8,646 | 817,500 | 819.7 K to 817.5 K (-0.27 %) |
Feb 26 2004 | GNSC | GENAISSANCE PHARMA ... | BLACK HILL INVESTMENT ADVISORS ... | 10% Owner | Sell | S | 3.70 | 15,300 | 56,610 | 819,700 | 835 K to 819.7 K (-1.83 %) |
Feb 26 2004 | GNSC | GENAISSANCE PHARMA ... | BLACK HILL INVESTMENT ADVISORS ... | 10% Owner | Sell | S | 3.80 | 1,200 | 4,560 | 835,000 | 836.2 K to 835 K (-0.14 %) |
Feb 26 2004 | GNSC | GENAISSANCE PHARMA ... | BLACK HILL INVESTMENT ADVISORS ... | 10% Owner | Sell | S | 3.86 | 8,800 | 33,968 | 836,200 | 845 K to 836.2 K (-1.04 %) |
Feb 26 2004 | GNSC | GENAISSANCE PHARMA ... | BLACK HILL INVESTMENT ADVISORS ... | 10% Owner | Sell | S | 3.52 | 32,500 | 114,400 | 845,000 | 877.5 K to 845 K (-3.70 %) |
Feb 11 2004 | GNSC | GENAISSANCE PHARMA ... | RITCHIE CAPITAL MANAGEMENT LLC | 10% Owner | Sell | S | 3.96 | 2,000 | 7,920 | 795,500 | 797.5 K to 795.5 K (-0.25 %) |
Feb 11 2004 | GNSC | GENAISSANCE PHARMA ... | RITCHIE CAPITAL MANAGEMENT LLC | 10% Owner | Sell | S | 4.07 | 20,000 | 81,400 | 797,500 | 817.5 K to 797.5 K (-2.45 %) |
Feb 11 2004 | GNSC | GENAISSANCE PHARMA ... | RITCHIE CAPITAL MANAGEMENT LLC | 10% Owner | Sell | S | 3.93 | 2,200 | 8,646 | 817,500 | 819.7 K to 817.5 K (-0.27 %) |
Feb 11 2004 | GNSC | GENAISSANCE PHARMA ... | RITCHIE CAPITAL MANAGEMENT LLC | 10% Owner | Sell | S | 3.70 | 15,300 | 56,610 | 819,700 | 835 K to 819.7 K (-1.83 %) |
Feb 11 2004 | GNSC | GENAISSANCE PHARMA ... | RITCHIE CAPITAL MANAGEMENT LLC | 10% Owner | Sell | S | 3.80 | 1,200 | 4,560 | 835,000 | 836.2 K to 835 K (-0.14 %) |
Feb 11 2004 | GNSC | GENAISSANCE PHARMA ... | RITCHIE CAPITAL MANAGEMENT LLC | 10% Owner | Sell | S | 3.86 | 8,800 | 33,968 | 836,200 | 845 K to 836.2 K (-1.04 %) |
Feb 11 2004 | GNSC | GENAISSANCE PHARMA ... | RITCHIE CAPITAL MANAGEMENT LLC | 10% Owner | Sell | S | 3.52 | 32,500 | 114,400 | 845,000 | 877.5 K to 845 K (-3.70 %) |
Page: 1